Join Us at Advanced Therapies Week 2025
Scalability Without Compromising Quality: Batch Size vs. Consistency vs. Cost
Date: January 22, 2025
Time: 1:20 PM
Track: Cell Therapy Manufacturing
About the Session
- Importance of Preserving Cell Health: Throughout cell handling processes including cell recovery, washing and concentration, maintaining cell function and quality is critical for product efficacy. Developers must focus on preserving the desired cell quality profile during handling, being mindful of cell experiences such as shear forces, prolonged reagent exposure, and time between controlled environments.
- Scalable Processing Framework: Implementing scalable processes early in the product development cycle is essential. Rigorous characterization of critical process parameters—such as separation force, buffer washes, and throughput—ensures that cell health and viability is maintained during scale-up, ultimately contributing to the scalability and cost-effectiveness of cell therapy products as they advance to market.
About CARR Biosystems
CARR Biosystems is dedicated to transforming bioprocessing workflows across multiple markets, including gene therapy, cell therapy, vaccines, biologics, cellular agriculture, nucleic acids and microbial fermentation. Our innovative centrifuge solutions are engineered to deliver unmatched scalability, precision, and efficiency, empowering our partners to accelerate the development and production of life-saving therapies.
By providing advanced technologies that seamlessly transition from process development to commercial-scale manufacturing, we help our customers achieve consistent product quality, reduce operational complexities, enhance overall productivity and improved process economics. Whether supporting emerging cell-based therapies or biomolecules, CARR Biosystems stands as a trusted partner in advancing global healthcare innovation.
